Literature DB >> 4879578

Suspension culture of a pigment-producing cell line derived from a human malignant melanoma.

H F Oettgen, T Aoki, L J Old, E A Boyse, E de Harven, G M Mills.   

Abstract

Entities:  

Mesh:

Year:  1968        PMID: 4879578

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  21 in total

Review 1.  [The immunology of malignant melanoma (author's transl)].

Authors:  G Schieferstein
Journal:  Klin Wochenschr       Date:  1978-03-15

2.  Circulating antibodies in human malignant disease.

Authors:  J M Whitehouse
Journal:  Br J Cancer Suppl       Date:  1973-08

3.  Diffusion chamber culture of hamster melanoma cells in vivo. Culture characteristics in iso- and heterologous host animals.

Authors:  G Schieferstein; O D Laerum
Journal:  Arch Dermatol Forsch       Date:  1974

Review 4.  Evidence for antigenicity in human tumours with reference to both melanoma and acute leukaemia.

Authors:  G H Fairley
Journal:  Br Med J       Date:  1970-11-21

5.  Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy.

Authors:  D L Morton; F R Eilber; W L Joseph; W C Wood; E Trahan; A S Ketcham
Journal:  Ann Surg       Date:  1970-10       Impact factor: 12.969

6.  Human melanoma FUHS-1. Description of a new cell line.

Authors:  V Misgeld; C Meisel
Journal:  Arch Dermatol Forsch       Date:  1975

7.  Establishment of a cell line (SH-4) from pleural effusion of a patient with melanoma.

Authors:  G Seman; S J Hunter; J M Lukeman; L Dmochowski
Journal:  In Vitro       Date:  1975 Jul-Aug

8.  [Immunfluorescence of human brain tumours (author's transl)].

Authors:  D K Böker
Journal:  Acta Neurochir (Wien)       Date:  1978       Impact factor: 2.216

9.  Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease.

Authors:  M G Lewis; R L Ikonopisov; R C Nairn; T M Phillips; G H Fairley; D C Bodenham; P Alexander
Journal:  Br Med J       Date:  1969-09-06

10.  BCG immunotherapy of malignant melanoma: summary of a seven-year experience.

Authors:  D L Morton; F R Eilber; E C Holmes; J S Hunt; A S Ketcham; M J Silverstein; F C Sparks
Journal:  Ann Surg       Date:  1974-10       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.